Shopping Cart
- Remove All
Your shopping cart is currently empty
trans-Urocanic Acid ((E)-Urocanic acid), a compound predominantly distributed in the hippocampus and prefrontal cortex, is an isomer of cis-UCA, an epidermal UV-protectant, which enhances the stability of tenofovir eplerenomide in long-acting HIV applications. trans-Urocanic acid potently modulates immune trans-urocanic acid effectively modulates immune function, inhibits human natural killer cell activity in vitro, and can be used in Alzheimer's disease research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 g | $30 | In Stock |
| Description | trans-Urocanic Acid ((E)-Urocanic acid), a compound predominantly distributed in the hippocampus and prefrontal cortex, is an isomer of cis-UCA, an epidermal UV-protectant, which enhances the stability of tenofovir eplerenomide in long-acting HIV applications. trans-Urocanic acid potently modulates immune trans-urocanic acid effectively modulates immune function, inhibits human natural killer cell activity in vitro, and can be used in Alzheimer's disease research. |
| In vitro | In primary human keratinocytes, trans-Urocanic acid (100 μg/mL; 24 hours) reduces cell proliferation and viability[2]. |
| Synonyms | trans-UCA, (E)-Urocanic acid |
| Molecular Weight | 138.12 |
| Formula | C6H6N2O2 |
| Cas No. | 3465-72-3 |
| Smiles | C(=C/C(O)=O)\C1=CN=CN1 |
| Relative Density. | 1.430 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||||||||||||
| Solubility Information | PBS (pH 7.2): 0.3 mg/mL (2.17 mM), Sonication is recommended. DMSO: 15 mg/mL (108.6 mM), Sonication is recommended. DMF: 3 mg/mL (21.72 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (14.48 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||||||||||||
PBS (pH 7.2)/DMF/DMSO
DMF/DMSO
DMSO
| ||||||||||||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.